<--- Back to Details
First PageDocument Content
Clinical medicine / Neurochemistry / Medicine / Sodium channel blockers / Alglucosidase alfa / Calcium channel blockers / Glycogen storage disease type II / Ketamine / Treprostinil / Eptifibatide
Date: 2010-05-26 09:39:24
Clinical medicine
Neurochemistry
Medicine
Sodium channel blockers
Alglucosidase alfa
Calcium channel blockers
Glycogen storage disease type II
Ketamine
Treprostinil
Eptifibatide

LUMIZYME (alglucosidase alfa) for Injection

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 245,04 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xP0D - View Document

PDF Document

DocID: 1xwIA - View Document

PDF Document

DocID: 1wM4L - View Document

UPCOMING CONFERENCES FOR THE ISN/JNC CONFERENCE November 12-16, 2016, San Diego, CA, USA 45th Annual Meeting of the Society for Neuroscience www.sfn.org/annual-meeting/past-and-future-annual-meetings December 5-7, 2016,

DocID: 1vmTe - View Document

conferenceseries.com 24th International Conference on Neuroscience and Neurochemistry July 23-24, 2018 Birmingham, UK

DocID: 1uCOn - View Document